Jennifer Lachey

Insider Reports History

Entity
Individual
Location
C/O Keros Therapeutics, Inc., 99 Hayden Avenue, Suite 120, Building E, Lexington, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer Lachey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Chief Scientific Officer Common Stock 95.1K $4.31M $45.29 Jul 15, 2022 Direct
Keros Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 8.76K Jul 15, 2022 Direct

Insider Reports Filed by Jennifer Lachey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. Jul 15, 2022 3 -$1.37M 4 Jul 19, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jul 13, 2022 3 -$56.9K 4 Jul 15, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jun 14, 2022 2 $2.82K 4 Jun 14, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. May 11, 2022 7 -$220K 4 May 13, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Apr 11, 2022 6 -$331K 4 Apr 13, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Apr 4, 2022 3 -$475K 4 Apr 6, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Mar 11, 2022 5 -$141K 4 Mar 15, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Feb 11, 2022 5 -$137K 4 Feb 15, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jan 21, 2022 1 $0 4 Jan 25, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jan 11, 2022 5 -$142K 4 Jan 13, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jan 5, 2022 3 -$158K 4 Jan 7, 2022 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Dec 13, 2021 8 -$133K 4 Dec 15, 2021 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Nov 10, 2021 7 -$1.26M 4 Nov 12, 2021 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Nov 4, 2021 3 -$527K 4 Nov 5, 2021 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Aug 17, 2021 2 $388 4 Aug 18, 2021 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jun 24, 2021 2 $1.95K 4 Jun 25, 2021 Chief Scientific Officer
KROS Keros Therapeutics, Inc. Jun 11, 2021 5 -$134K 4 Jun 15, 2021 Chief Scientific Officer
KROS Keros Therapeutics, Inc. May 11, 2021 7 -$131K 4 May 13, 2021 Chief Scientific Officer